Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) General Information

Description

Commercial rights of the ATX-101. The asset includes all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 51368 Leverkusen
  • Germany
Primary Industry
Buildings and Property
Acquirer
Kythera Biopharmaceuticals
Corporate Office
  • 51368 Leverkusen
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)‘s full profile, request access.

Request a free trial

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)‘s full profile, request access.

Request a free trial

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) FAQs

  • Where is Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) headquartered?

    Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) is headquartered in Leverkusen, Germany.

  • What industry is Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) in?

    Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)’s primary industry is Buildings and Property.

  • Is Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) a private or public company?

    Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) is a Private company.

  • What is the current valuation of Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)?

    The current valuation of Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) is 0000.

  • What is Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)’s current revenue?

    The current revenue for Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) is 000000.

  • Who are Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)’s investors?

    Bayer Consumer Care has invested in Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada).

  • When was Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) acquired?

    Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) was acquired on 10-Mar-2014.

  • Who acquired Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)?

    Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) was acquired by Kythera Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »